|
US10865245B2
(en)
|
2014-12-23 |
2020-12-15 |
Full Spectrum Genetics, Inc. |
Anti-B7H3 binding compounds and uses thereof
|
|
US9963509B2
(en)
*
|
2014-12-23 |
2018-05-08 |
Full Spectrum Genetics, Inc. |
Anti-B7H3 binding compounds and uses thereof
|
|
WO2016207104A1
(de)
*
|
2015-06-23 |
2016-12-29 |
Bayer Pharma Aktiengesellschaft |
Antikörper-wirkstoff-konjugate (adcs) von ksp-inhibitoren mit anti-b7h3-antikörpern
|
|
US12128102B2
(en)
|
2016-03-08 |
2024-10-29 |
Takeda Pharmaceutical Company Limited |
Constrained conditionally activated binding proteins
|
|
WO2018006066A1
(en)
*
|
2016-07-01 |
2018-01-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
Inhibitory immune receptor inhibition methods and compositions
|
|
CA3050085A1
(en)
|
2017-01-20 |
2018-07-26 |
Juno Therapeutics Gmbh |
Cell surface conjugates and related cell compositions and methods
|
|
CN109843927B
(zh)
*
|
2017-03-06 |
2022-06-21 |
江苏恒瑞医药股份有限公司 |
抗b7-h3抗体、其抗原结合片段及其医药用途
|
|
MX2019011117A
(es)
|
2017-03-31 |
2019-11-05 |
Jiangsu Hengrui Medicine Co |
Anticuerpo b7-h3, fragmento de union a antigeno de los mismos y uso medico de los mismos.
|
|
SG11201909160WA
(en)
|
2017-04-11 |
2019-10-30 |
Inhibrx Inc |
Multispecific polypeptide constructs having constrained cd3 binding and methods of using the same
|
|
RU2019140833A
(ru)
*
|
2017-05-12 |
2021-06-15 |
Мемориал Слоан-Кеттеринг Кэнсер Сентер |
Применение антител против в7н3 для лечения злокачественных опухолей в центральной нервной системе
|
|
CN109963591B
(zh)
*
|
2017-08-04 |
2023-04-04 |
江苏恒瑞医药股份有限公司 |
B7h3抗体-药物偶联物及其医药用途
|
|
WO2019032628A1
(en)
|
2017-08-07 |
2019-02-14 |
The Regents Of The University Of California |
GENERATING PLATFORM FOR SAFE CELLULAR THERAPEUTIC AGENTS
|
|
WO2019036687A1
(en)
|
2017-08-17 |
2019-02-21 |
Miller Michael D |
SYSTEM AND METHOD FOR FIREARM ASSEMBLY
|
|
CN111356700A
(zh)
|
2017-09-08 |
2020-06-30 |
马弗里克治疗公司 |
受约束的条件性活化的结合蛋白
|
|
WO2019080883A1
(en)
*
|
2017-10-26 |
2019-05-02 |
Immuneonco Biopharmaceuticals (Shanghai) Co., Ltd. |
NOVEL RECOMBINANT FUSION PROTEINS, PREPARATION THEREOF AND USE THEREOF
|
|
CN111511392A
(zh)
|
2017-10-31 |
2020-08-07 |
潘塔希生物科学股份有限公司 |
用于治疗和/或预防肺癌的免疫治疗方法
|
|
CN109939126A
(zh)
*
|
2017-12-21 |
2019-06-28 |
张曼 |
Cd3×b7h3双特异抗体定向杀伤耐阿霉素膀胱癌细胞pumc-91/adm的应用
|
|
CN109939231A
(zh)
*
|
2017-12-21 |
2019-06-28 |
张曼 |
关于cd3×b7h3双特异性抗体定向杀伤膀胱癌细胞t24的应用
|
|
KR102896085B1
(ko)
*
|
2018-01-15 |
2025-12-08 |
스티흐팅 산퀸 불드포르지닝 |
인자 h 강화 항체 및 이의 사용
|
|
CN111699200B
(zh)
|
2018-01-15 |
2023-05-26 |
南京传奇生物科技有限公司 |
针对pd-1的单域抗体和其变体
|
|
KR20260046525A
(ko)
|
2018-04-11 |
2026-04-07 |
인히브릭스 바이오사이언스, 인크. |
제한된 cd3 결합을 갖는 다중특이적 폴리펩티드 컨스트럭트 및 관련된 방법 및 용도
|
|
WO2019225787A1
(ko)
|
2018-05-24 |
2019-11-28 |
에이비엘바이오 주식회사 |
항-b7-h3 항체 및 그 용도
|
|
KR20210035805A
(ko)
|
2018-06-15 |
2021-04-01 |
플래그쉽 파이어니어링 이노베이션스 브이, 인크. |
세포후 신호전달 인자의 조절을 통한 면역 활성의 증가
|
|
WO2020018964A1
(en)
|
2018-07-20 |
2020-01-23 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for controlled expression of antigen-specific receptors
|
|
EP3827019A1
(en)
|
2018-07-24 |
2021-06-02 |
Inhibrx, Inc. |
Multispecific polypeptide constructs containing a constrained cd3 binding domain and a receptor binding region and methods of using the same
|
|
US12274759B2
(en)
|
2018-08-23 |
2025-04-15 |
Regents Of The University Of Minnesota |
Affibody proteins specific for B7-H3 (CD276)
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
CN113166261A
(zh)
*
|
2018-10-11 |
2021-07-23 |
印希比股份有限公司 |
B7h3单域抗体及其治疗性组合物
|
|
AU2018449846B2
(en)
*
|
2018-11-22 |
2023-12-14 |
Beijing Kanova Biopharmaceutical Co., Ltd. |
An anti-B7-H3 antibody
|
|
EP4592313A3
(en)
|
2019-03-05 |
2025-11-19 |
Takeda Pharmaceutical Company Limited |
Constrained conditionally activated binding proteins
|
|
CN109929039A
(zh)
*
|
2019-03-28 |
2019-06-25 |
郑州大学第一附属医院 |
基于cd276抗体的嵌合抗原受体、慢病毒表达载体及其应用
|
|
WO2020227159A2
(en)
|
2019-05-03 |
2020-11-12 |
Flagship Pioneering Innovations V, Inc. |
Methods of modulating immune activity
|
|
WO2020232247A1
(en)
|
2019-05-14 |
2020-11-19 |
Provention Bio, Inc. |
Methods and compositions for preventing type 1 diabetes
|
|
US20220235134A1
(en)
*
|
2019-05-28 |
2022-07-28 |
Single Cell Technology, Inc. |
Anti-b7-h3 antibodies
|
|
US12441802B2
(en)
|
2019-07-03 |
2025-10-14 |
Crystal Bioscience Inc. |
Anti-B7-H3 antibody and methods of use thereof
|
|
KR102732027B1
(ko)
|
2019-07-09 |
2024-11-20 |
주식회사 와이바이오로직스 |
B7-h3(cd276)에 특이적으로 결합하는 항체 및 그의 용도
|
|
TWI851771B
(zh)
|
2019-07-17 |
2024-08-11 |
美商雙子治療子公司 |
因子ｈ增強抗體及其用途
|
|
EP4022313A1
(en)
|
2019-08-30 |
2022-07-06 |
Y-Mabs Therapeutics, Inc. |
Immunohistochemical assessment of b7-h3 expression
|
|
CN110642948B
(zh)
*
|
2019-10-09 |
2021-06-29 |
达石药业(广东)有限公司 |
B7-h3纳米抗体、其制备方法及用途
|
|
AU2020387401A1
(en)
*
|
2019-11-18 |
2022-05-26 |
Board Of Regents, The University Of Texas System |
Anti-B7-H3 monoclonal antibody and methods of use thereof
|
|
US20230114107A1
(en)
|
2019-12-17 |
2023-04-13 |
Flagship Pioneering Innovations V, Inc. |
Combination anti-cancer therapies with inducers of iron-dependent cellular disassembly
|
|
JP7789002B2
(ja)
|
2020-01-29 |
2025-12-19 |
インヒブルクス バイオサイエンシズ インコーポレイテッド |
Ｃｄ２８シングルドメイン抗体ならびにその多価および多重特異性の構築物
|
|
EP4138931A1
(en)
*
|
2020-04-24 |
2023-03-01 |
Y-Mabs Therapeutics, Inc. |
B7h3 antibodies with chelators
|
|
CA3178510A1
(en)
*
|
2020-06-04 |
2021-12-09 |
Ahmed Mahiuddin |
Anti-b7h3 antibodies for the treatment of cancer
|
|
IL298999A
(en)
|
2020-06-11 |
2023-02-01 |
Provention Bio Inc |
Methods and compositions for the prevention of type 1 diabetes
|
|
US20230355804A1
(en)
|
2020-06-29 |
2023-11-09 |
Flagship Pioneering Innovations V, Inc. |
Viruses engineered to promote thanotransmission and their use in treating cancer
|
|
CN111662384B
(zh)
|
2020-06-30 |
2021-04-09 |
广州百暨基因科技有限公司 |
抗b7h3抗体及其应用
|
|
AR124414A1
(es)
|
2020-12-18 |
2023-03-22 |
Century Therapeutics Inc |
Sistema de receptor de antígeno quimérico con especificidad de receptor adaptable
|
|
KR20230124959A
(ko)
*
|
2020-12-23 |
2023-08-28 |
이노벤트 바이오로직스 (쑤저우) 컴퍼니, 리미티드 |
항-b7-h3 항체 및 이의 용도
|
|
EP4257154A4
(en)
|
2021-02-09 |
2026-04-22 |
Medilink Therapeutics Suzhou Co Ltd |
CONJUGATED WITH A BIOACTIVE SUBSTANCE, ITS PREPARATION PROCESS AND ITS USE
|
|
EP4313109A1
(en)
|
2021-03-31 |
2024-02-07 |
Flagship Pioneering Innovations V, Inc. |
Thanotransmission polypeptides and their use in treating cancer
|
|
JP2024520444A
(ja)
|
2021-05-24 |
2024-05-24 |
プロヴェンション・バイオ・インコーポレイテッド |
１型糖尿病を治療するための方法
|
|
AU2022303363A1
(en)
|
2021-06-29 |
2024-01-18 |
Flagship Pioneering Innovations V, Inc. |
Immune cells engineered to promote thanotransmission and uses thereof
|
|
MX2024003320A
(es)
*
|
2021-09-18 |
2024-06-28 |
Skyline Therapeutics Ltd |
Virus adenoasociado para terapia génica de degeneración macular húmeda asociada con la edad.
|
|
EP4413046A4
(en)
*
|
2021-10-05 |
2025-11-26 |
Univ Texas |
PROCESSES AND COMPOSITIONS COMPRISING B7-H3 BONDING POLYPEPTIDES
|
|
WO2023134716A1
(zh)
*
|
2022-01-14 |
2023-07-20 |
盛禾(中国)生物制药有限公司 |
一种结合b7h3和nkp30的双特异性抗体及其应用
|
|
CN118647408A
(zh)
|
2022-02-16 |
2024-09-13 |
苏州宜联生物医药有限公司 |
抗体-艾日布林或其衍生物的偶联物、其中间体、制备方法、药物组合物和用途
|
|
WO2023178192A1
(en)
|
2022-03-15 |
2023-09-21 |
Compugen Ltd. |
Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancer
|
|
CN116836281A
(zh)
*
|
2022-03-25 |
2023-10-03 |
英诺湖医药(杭州)有限公司 |
B7h3抗体及包含其的双功能抗体
|
|
CN119212733A
(zh)
|
2022-05-18 |
2024-12-27 |
苏州宜联生物医药有限公司 |
包含蛋白降解剂类生物活性化合物的抗体药物偶联物及其制备方法和用途
|
|
CA3253563A1
(en)
*
|
2022-05-18 |
2023-11-23 |
WuXi Biologics Ireland Limited |
ANTI-B7H3 ANTIBODIES AND THEIR USES
|
|
CN119768434A
(zh)
*
|
2022-08-19 |
2025-04-04 |
盛禾(中国)生物制药有限公司 |
一种双特异性抗体及其应用
|
|
US20240174732A1
(en)
|
2022-10-05 |
2024-05-30 |
Flagship Pioneering Innovations V, Inc. |
Nucleic acid molecules encoding trif and additional polypeptides and their use in treating cancer
|
|
CN115819608A
(zh)
*
|
2022-10-08 |
2023-03-21 |
盛禾(中国)生物制药有限公司 |
一种纯化融合蛋白的方法
|
|
CN115845047A
(zh)
*
|
2022-11-07 |
2023-03-28 |
盛禾(中国)生物制药有限公司 |
一种异源二聚体蛋白质组合物
|
|
WO2024106939A1
(ko)
*
|
2022-11-15 |
2024-05-23 |
주식회사 셀랩메드 |
B7-h3에 특이적으로 결합하는 항체
|
|
WO2024151687A1
(en)
|
2023-01-09 |
2024-07-18 |
Flagship Pioneering Innovations V, Inc. |
Genetic switches and their use in treating cancer
|
|
TW202515608A
(zh)
|
2023-06-26 |
2025-04-16 |
以色列商坎布根有限公司 |
Ｉｌ—１８ｂｐ拮抗抗體及其於癌症治療之單一療法及組合療法的用途
|
|
WO2025129565A1
(zh)
*
|
2023-12-21 |
2025-06-26 |
西湖实验室(生命科学和生物医学浙江省实验室) |
一种cd276迷你结合蛋白及其突变体及应用
|
|
WO2025245264A1
(en)
|
2024-05-21 |
2025-11-27 |
Briapro Therapeutics Corp. |
Anti-b7-h3 antibodies and methods of use thereof
|